Nektar Therapeutics Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Nektar Therapeutics · Nektar Therapeutics securities · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Nektar Therapeutics
- Product or service
- Nektar Therapeutics securities
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Other
Important dates
- Lead plaintiff application
Participation information
Availability is based on each listed participation option and its deadline.
Lead plaintiff application
Shareholders who purchased Nektar Therapeutics shares from February 26, 2025 through December 15, 2025 may seek appointment as lead plaintiff.
Contact The Gross Law Firm regarding possible lead plaintiff appointment.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.